Evidence map›Paper›PMID 27507776›Full record

ArticleScientific reports2016

Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.

Armin Biller, Isabella Pflugmann, Stephanie Badde, Ricarda Diem, Brigitte Wildemann, Armin M Nagel, J Jordan, Nadia Benkhedah, Jens Kleesiek

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Triple-PulseMagnetic resonance in medicine · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Sodium homeostasis in the tumour microenvironment.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  10. Review
  11. Review
  12. Article
  13. The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Armin BillerMulti-Dimensional Medical Imaging Lab, Department of Neuroradiology, University of Heidelberg, 69120 Heidelberg, Germany.
Isabella PflugmannMulti-Dimensional Medical Imaging Lab, Department of Neuroradiology, University of Heidelberg, 69120 Heidelberg, Germany.
Stephanie BaddeDepartment of Biological Psychology and Neuropsychology, University of Hamburg, 20146 Hamburg, Germany.
Ricarda DiemDepartment of Neurology, University of Heidelberg, 69120 Heidelberg, Germany.
Brigitte WildemannMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, 69120 Heidelberg, Germany.
Armin M NagelDivision of Medical Physics in Radiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
J JordanDivision of Medical Physics in Radiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
Nadia BenkhedahDivision of Medical Physics in Radiology, German Cancer Research Centre (DKFZ), 69120 Heidelberg, Germany.
Jens KleesiekMulti-Dimensional Medical Imaging Lab, Department of Neuroradiology, University of Heidelberg, 69120 Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cascade of inflammatory pathogenetic mechanisms in multiple sclerosis (MS) has no specific conventional MRI correlates. Clinicians therefore stipulate improved imaging specificity to define the pathological substrates of MS in vivo including mapping of intracellular sodium accumulation. Based upon preclinical findings and results of previous sodium MRI studies in MS patients we hypothesized that the fluid-attenuated sodium signal differs between acute and chronic lesions. We acquired brain sodium and proton MRI data of N = 29 MS patients; lesion type was defined by the presence or absence of contrast enhancement. N = 302 MS brain lesions were detected, and generalized linear mixed models were applied to predict lesion type based on sodium signals; thereby controlling for varying numbers of lesions among patients and confounding variables such as age and medication. Hierarchical model comparisons revealed that both sodium signals average tissue (χ(2)(1) = 27.89, p < 0.001) and fluid-attenuated (χ(2)(1) = 5.76, p = 0.016) improved lesion type classification. Sodium MRI signals were significantly elevated in acute compared to chronic lesions compatible with intracellular sodium accumulation in acute MS lesions. If confirmed in further studies, sodium MRI could serve as biomarker for diagnostic assessment of MS, and as readout parameter in clinical trials promoting attenuation of chronic inflammation.

Indexed as

Magnetic Resonance ImagingAcute DiseaseAdolescentAdultBrainChronic DiseaseFemaleHumansInflammationLinear ModelsMaleMultiple SclerosisSodiumYoung AdultSodium

Identifiers

PMID27507776
PMCPMC4978993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.